Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dae Wook Hwang

Showing results (181-190 of 227) with videos related to

Pageof 23
Sort By:
Annals of Hepato-Biliary-Pancreatic Surgery|December 28, 2018
Impact of preoperative management in patients older than 80 years requiring cholecystectomyDa-Kyum Shin, Seok-Hwan Kim, Deok-Bog Moon, et al.
Cancer Cell International|April 25, 2017
Establishment and characterization of 6 novel patient-derived primary pancreatic ductal adenocarcinoma cell lines from Korean pancreatic cancer patientsMi-Ju Kim, Min-Sun Kim, Sung Joo Kim, et al.
Journal of Clinical Medicine|May 20, 2020
Reduced and Normalized Carbohydrate Antigen 19-9 Concentrations after Neoadjuvant Chemotherapy Have Comparable Prognostic Performance in Patients with Borderline Resectable and Locally Advanced Pancreatic CancerWoohyung Lee, Yejong Park, Jae Woo Kwon, et al.
Cancer Research and Treatment|May 4, 2023
Analysis of Plasma Circulating Tumor DNA in Borderline Resectable Pancreatic Cancer Treated with Neoadjuvant Modified FOLFIRINOX: Clinical Relevance of DNA Damage Repair Gene Alteration DetectionDong-Hoon Lim, Hyunseok Yoon, Kyu-Pyo Kim, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|August 23, 2018
Clinicopathologic Characteristics and Optimal Surgical Treatment of Duodenal Gastrointestinal Stromal TumorSeung Jae Lee, Ki Byung Song, Young-Joo Lee, et al.
Scientific Reports|February 18, 2017
Novel Preoperative Nomogram for Prediction of Futile Resection in Patients Undergoing Exploration for Potentially Resectable Intrahepatic CholangiocarcinomaKwangwoo Nam, Dae Wook Hwang, Ju Hyun Shim, et al.
Annals of Surgical Oncology|May 7, 2026
Modified FOLFIRINOX with or Without Stereotactic Body Radiation in Locally Advanced Unresectable Pancreatic Cancer (SABER): A Randomized Open-Label Phase 2 TrialChanghoon Yoo, Hyehyun Jeong, Inkeun Park, et al.
Human Pathology|September 28, 2018
High-grade precursor lesions can be used as surrogate markers to identify the epicenter of periampullary carcinomasByung-Kwan Jeong, You Na Sung, Sung Joo Kim, et al.
Hepatology (Baltimore, Md.)|April 18, 2023
Adjuvant gemcitabine plus cisplatin versus capecitabine in node-positive extrahepatic cholangiocarcinoma: the STAMP randomized trialHyehyun Jeong, Kyu-Pyo Kim, Jae Ho Jeong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2016
Alternative Lengthening of Telomeres in Primary Pancreatic Neuroendocrine Tumors Is Associated with Aggressive Clinical Behavior and Poor SurvivalJoo Young Kim, Jacqueline A Brosnan-Cashman, Soyeon An, et al.
Pageof 23

Showing results (181-190 of 227) with videos related to

Sort By:
Pageof 23
Annals of Hepato-Biliary-Pancreatic Surgery|December 28, 2018
Impact of preoperative management in patients older than 80 years requiring cholecystectomyDa-Kyum Shin, Seok-Hwan Kim, Deok-Bog Moon, et al.
Cancer Cell International|April 25, 2017
Establishment and characterization of 6 novel patient-derived primary pancreatic ductal adenocarcinoma cell lines from Korean pancreatic cancer patientsMi-Ju Kim, Min-Sun Kim, Sung Joo Kim, et al.
Journal of Clinical Medicine|May 20, 2020
Reduced and Normalized Carbohydrate Antigen 19-9 Concentrations after Neoadjuvant Chemotherapy Have Comparable Prognostic Performance in Patients with Borderline Resectable and Locally Advanced Pancreatic CancerWoohyung Lee, Yejong Park, Jae Woo Kwon, et al.
Cancer Research and Treatment|May 4, 2023
Analysis of Plasma Circulating Tumor DNA in Borderline Resectable Pancreatic Cancer Treated with Neoadjuvant Modified FOLFIRINOX: Clinical Relevance of DNA Damage Repair Gene Alteration DetectionDong-Hoon Lim, Hyunseok Yoon, Kyu-Pyo Kim, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|August 23, 2018
Clinicopathologic Characteristics and Optimal Surgical Treatment of Duodenal Gastrointestinal Stromal TumorSeung Jae Lee, Ki Byung Song, Young-Joo Lee, et al.
Scientific Reports|February 18, 2017
Novel Preoperative Nomogram for Prediction of Futile Resection in Patients Undergoing Exploration for Potentially Resectable Intrahepatic CholangiocarcinomaKwangwoo Nam, Dae Wook Hwang, Ju Hyun Shim, et al.
Annals of Surgical Oncology|May 7, 2026
Modified FOLFIRINOX with or Without Stereotactic Body Radiation in Locally Advanced Unresectable Pancreatic Cancer (SABER): A Randomized Open-Label Phase 2 TrialChanghoon Yoo, Hyehyun Jeong, Inkeun Park, et al.
Human Pathology|September 28, 2018
High-grade precursor lesions can be used as surrogate markers to identify the epicenter of periampullary carcinomasByung-Kwan Jeong, You Na Sung, Sung Joo Kim, et al.
Hepatology (Baltimore, Md.)|April 18, 2023
Adjuvant gemcitabine plus cisplatin versus capecitabine in node-positive extrahepatic cholangiocarcinoma: the STAMP randomized trialHyehyun Jeong, Kyu-Pyo Kim, Jae Ho Jeong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2016
Alternative Lengthening of Telomeres in Primary Pancreatic Neuroendocrine Tumors Is Associated with Aggressive Clinical Behavior and Poor SurvivalJoo Young Kim, Jacqueline A Brosnan-Cashman, Soyeon An, et al.
Pageof 23